Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Russell P. Goodman"'
Publikováno v:
JCI Insight, Vol 7, Iss 14 (2022)
Despite being a leading cause of advanced liver disease, alcohol-associated liver disease (ALD) has no effective medical therapies. The circulating proteome, which comprises proteins secreted by different cells and tissues in the context of normal ph
Externí odkaz:
https://doaj.org/article/cff9f8ddfd904a31b67e7dccf3cd7a92
Autor:
Rachael Mahle, Paige McLean Diaz, Chantelle Marshall, Russell P. Goodman, Esperance Schaefer, Jay Luther
Publikováno v:
Hepatology Communications. 7
Autor:
Augustin G L, Vannier, Eric M, Przybyszewski, Jessica, Shay, Suraj J, Patel, Esperance, Schaefer, Russell P, Goodman, Jay, Luther
Publikováno v:
Clinical Gastroenterology and Hepatology. 21:1571-1580.e7
Alcohol-associated liver disease (ALD) is a devastating complication of alcohol use disorder (AUD). Once it develops, ALD is exceedingly difficult to treat; it therefore is critical to identify ways to prevent ALD. By treating the causes of increased
Autor:
Ashwin N. Ananthakrishnan, Lee M. Kaplan, Ricard Masia, Russell P. Goodman, Manish Gala, Kathleen E. Corey, N. Borren, Andrew Warren, Raymond T. Chung, Suraj J. Patel, Martin L. Yarmush, Alyssa C. Ehrlich, Sangeeta N. Bhatia, Erik DiGiacomo, Ida J Hatoum Moeller, Jay Luther
Publikováno v:
Hepatology Communications
Emerging data highlight the critical role for the innate immune system in the progression of nonalcoholic fatty liver disease (NAFLD). Connexin 32 (Cx32), the primary liver gap junction protein, is capable of modulating hepatic innate immune response
Autor:
Raymond T. Chung, Wenyu Lin, Esperance A. Schaefer, Jay Luther, Batul Kaj-Carbaidwala, shao tuo, Mozhdeh Sojoodi, Darrick K. Li, Russell P. Goodman, Sarani Ghoshal, Kenneth K. Tanabe, Rasha Elmaoued, Shadi Salloum
Publikováno v:
Gastroenterology. 158:S-1441
Autor:
Russell P. Goodman, Ricard Masia, John J. Garber, Raymond T. Chung, Suraj J. Patel, Jay Luther
Publikováno v:
Gastroenterology. 154:S-1118